Compare CCLD & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCLD | SGMO |
|---|---|---|
| Founded | 1999 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.1M | 155.1M |
| IPO Year | 2014 | 2000 |
| Metric | CCLD | SGMO |
|---|---|---|
| Price | $3.30 | $0.45 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $1.50 | ★ $4.71 |
| AVG Volume (30 Days) | 326.4K | ★ 9.2M |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $114,315,000.00 | $32,875,000.00 |
| Revenue This Year | $8.58 | $1.37 |
| Revenue Next Year | $12.06 | N/A |
| P/E Ratio | $43.20 | ★ N/A |
| Revenue Growth | ★ 2.97 | N/A |
| 52 Week Low | $1.14 | $0.38 |
| 52 Week High | $4.75 | $2.84 |
| Indicator | CCLD | SGMO |
|---|---|---|
| Relative Strength Index (RSI) | 58.60 | 43.51 |
| Support Level | $3.04 | $0.49 |
| Resistance Level | $3.35 | $0.51 |
| Average True Range (ATR) | 0.12 | 0.04 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 85.00 | 31.04 |
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.